Proteinuria and progression in human glomerular diseases.

Area of Science:

• Nephrology
• Pathology
• Molecular Biology

Background:

• Proteinuria is a hallmark of glomerular diseases, often exceeding 2-3 g/24 h.
• The mechanisms by which heavy proteinuria drives kidney disease progression are not fully elucidated.

Purpose of the Study:

• To explore the potential pathways linking proteinuria to the progression of underlying glomerular pathologies.
• To review evidence suggesting proteinuria-induced cellular damage, hyperlipidemia, and coagulation abnormalities contribute to kidney disease.

Main Methods:

• Review of existing literature on proteinuria and kidney disease progression.
• Analysis of experimental evidence from animal models of proteinuria.
• Correlation of clinical data on proteinuria duration/intensity with disease prognosis.

Main Results:

• Proteinuria can cause toxic protein transit through glomerular structures and proximal tubules.
• Secondary hyperlipidemia due to proteinuria may lead to glomerulosclerosis.
• Proteinuria-induced alterations in plasma proteins can increase platelet aggregability and affect coagulation cascades.

Conclusions:

• Multiple mechanisms, including cellular toxicity, hyperlipidemia, and hypercoagulability, may explain how proteinuria exacerbates kidney disease.
• Clinical prognosis in proteinuric states strongly correlates with proteinuria levels.
• Therapeutic strategies targeting proteinuria reduction warrant investigation for treating glomerulopathies.